Artemis Global Life Sciences Ltd((Merged)
Artemis Global Life Sciences is engaged in Healthcare Services.
- Market Cap ₹ 327 Cr.
- Current Price ₹ 49.4
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 23.9
- Dividend Yield 0.00 %
- ROCE -0.25 %
- ROE -0.08 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.04% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
---|---|---|---|---|---|---|
0.00 | 0.00 | 0.41 | 0.41 | 0.41 | 0.40 | |
0.01 | 0.22 | 0.05 | 0.53 | 0.65 | 0.66 | |
Operating Profit | -0.01 | -0.22 | 0.36 | -0.12 | -0.24 | -0.26 |
OPM % | 87.80% | -29.27% | -58.54% | -65.00% | ||
0.00 | 0.36 | 0.00 | -0.11 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.15 | 0.15 | 0.15 | 0.16 |
Profit before tax | -0.01 | 0.14 | 0.21 | -0.38 | -0.39 | -0.42 |
Tax % | 0.00% | 50.00% | 28.57% | -21.05% | -71.79% | |
-0.01 | 0.07 | 0.15 | -0.30 | -0.12 | -0.17 | |
EPS in Rs | -1.00 | 1.40 | 0.02 | -0.05 | -0.02 | -0.03 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 13% |
TTM: | 50% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 0% |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 0% |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
---|---|---|---|---|---|
Equity Capital | 0.10 | 0.10 | 13.24 | 13.24 | 13.24 |
Reserves | -0.05 | 0.02 | 145.60 | 145.30 | 145.18 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.01 | 0.08 | 3.52 | 3.38 | 3.29 | |
Total Liabilities | 0.06 | 0.20 | 162.36 | 161.92 | 161.71 |
0.00 | 0.00 | 1.92 | 1.77 | 1.62 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.05 | 0.00 | 159.91 | 159.91 | 159.91 |
0.01 | 0.20 | 0.53 | 0.24 | 0.18 | |
Total Assets | 0.06 | 0.20 | 162.36 | 161.92 | 161.71 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
---|---|---|---|---|---|
0.00 | 0.07 | 3.74 | -0.43 | -0.09 | |
0.00 | 0.05 | 0.00 | 0.00 | 0.00 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash Flow | 0.00 | 0.12 | 3.74 | -0.43 | -0.09 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
---|---|---|---|---|---|
Debtor Days | 0.00 | 97.93 | 0.00 | ||
Inventory Days | |||||
Days Payable | |||||
Cash Conversion Cycle | 0.00 | 97.93 | 0.00 | ||
Working Capital Days | -2,911.10 | -2,795.37 | -2,928.90 | ||
ROCE % | -258.82% | 0.26% | -0.17% | -0.25% |
Documents
Announcements
- Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 ('Listing Regulations') 22 Oct 2019
- Shareholding for the Period Ended September 30, 2019 16 Oct 2019
-
Statement Of Investor Complaints For The Quarter Ended September 2019
15 Oct 2019 - No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter …
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Oct 2019 - Notice published in the Newspaper - Intimation about the Record Date of the Composite Scheme of Amalgamation between Artemis Global Life Sciences Limited ('Company'), Artemis …
- Fixation Of Record Date - Regulation 30 And 42 Of SEBI (LODR) Regulations, 2015 (Revised) 14 Oct 2019